Historical record - last NADAC effective date: 6/21/2023
Product Information
QC ANTI-DIARRHEAL 2 MG SOFTGEL is a generic product labeled by Chain Drug Marketing Association, priced at $0.1492 per EA under NDC 63868087612. Its NADAC has been published 205 times since Jul 31, 2019.
FDA first approved this application on Aug 4, 2005.
Strength
2 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868087612
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021855FDA Approved
8/4/2005
On Market Since
1/25/2019
Pharmacological Classes
Price Statistics
The NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has been published 205 times since Jul 31, 2019, and over the history we have for it it has risen 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1492 per EA |
|---|---|
| All-time high | $0.1625 (Mar 11, 2020) |
| All-time low | $0.1194 (Jul 31, 2019) |
| Median price | $0.1423 |
| Average price | $0.1427 |
| Largest weekly change | -13.9% (Mar 18, 2020) |
| Weeks tracked | 205 |
| Tracking since | Jul 31, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+6.4%
All
+25.0%
Last surveyed Jun 28, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LOPERAMIDE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ANTI-DIARRHEAL 2 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for QC ANTI-DIARRHEAL 2 MG SOFTGEL, manufactured by Chain Drug Marketing Association, is $0.1492 per EA (NDC 63868087612), effective Jun 28, 2023.
How has the price of QC ANTI-DIARRHEAL 2 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has risen 25.0%. It has been tracked across 205 weekly CMS publications since Jul 31, 2019.
What are the highest and lowest recorded NADAC prices for QC ANTI-DIARRHEAL 2 MG SOFTGEL?
Since Jul 31, 2019, the NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has ranged from a low of $0.1194 (Jul 31, 2019) to a high of $0.1625 (Mar 11, 2020), with a median of $0.1423 per EA.
Are there cheaper alternatives to QC ANTI-DIARRHEAL 2 MG SOFTGEL?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOPERAMIDE 2 MG CAPSULE, is $0.0549 per EA — about 63% below QC ANTI-DIARRHEAL 2 MG SOFTGEL.
Who manufactures QC ANTI-DIARRHEAL 2 MG SOFTGEL?
QC ANTI-DIARRHEAL 2 MG SOFTGEL (NDC 63868087612) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.